Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ComInnex was a Hungary-based medicinal and synthetic chemistry company serving pharmaceutical, biotech, academic, nonprofit, and government customers in early-stage drug discovery. The company specialized in small molecule design and synthesis, custom compound libraries, DNA-encoded library building blocks, flow chemistry, photochemistry, and related discovery support services. It appears to have operated primarily as a contract research and enabling-technology provider rather than a therapeutic product developer with an internal clinical pipeline. In October 2021, ComInnex was acquired by X-Chem to expand X-Chem's global small-molecule discovery capabilities, particularly in synthetic chemistry and custom DEL services. Following the acquisition, ComInnex no longer appears to operate as an independent active company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ComInnex.